Notes
National Health Service
Reference
NICE. New option for people with difficult-to-treat multiple myeloma is recommended for use in Cancer Drugs Fund by NICE. Internet Document : 24 Nov 2020. Available from: URL: https://www.nice.org.uk/news/article/new-option-for-people-with-difficult-to-treat-multiple-myeloma-is-recommended-for-use-in-cancer-drugs-fund-by-nice
Rights and permissions
About this article
Cite this article
NICE recommends isatuximab with pomalidomide and dexamethasone. PharmacoEcon Outcomes News 867, 34 (2020). https://doi.org/10.1007/s40274-020-7331-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7331-2